Shares of Genomic Health Inc. (NASDAQ:GHDX) have been given a consensus recommendation of “Hold” by the ten analysts that are covering the stock. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The average 12-month price objective […]
